Luteolin and Tanshinone IIA showed high value in analyzing the relationship between SMB and ovarian cancer, the analysis of the relationship between the PI3K-Akt signaling pathway and SMB, and the analysis of patients' survival. This evidence concerns the gene AKT1 and ovarian carcinoma.